Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Onkologie
|
July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial
G. Hartung, R. Hofheinz, D. Buchheidt, et al.
Klinische Wochenschrift
|
February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum
D Fritze, B Massner, R Becher, et al.
Onkologie
|
April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"
H Flechtner, W Queisser, M E Heim, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]
A C Mayr, H J Senn, W M Gallmeier, et al.
American Journal of Surgery
|
November 1, 1976
Immunotherapy of cancer with "immune" RNA. A preliminary report
Y H Pilch, J B de Kernion, D G Skinner, et al.
Onkologie
|
November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer
G Hartung, R D Hofheinz, A Wein, et al.
Klinische Wochenschrift
|
June 15, 1982
A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer
D Fritze, R Becher, B Massner, et al.
International Journal of Systematic and Evolutionary Microbiology
|
July 2, 2009
Proposed minimal standards for describing new taxa of aerobic, endospore-forming bacteria
N A Logan, O Berge, A H Bishop, et al.
Anti-Cancer Drugs
|
August 13, 2005
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC
G von Minckwitz, I Chernozemsky, L Sirakova, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1981
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma
W Queisser, G Schnitzler, J Schaefer, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Onkologie
|
July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial
G. Hartung, R. Hofheinz, D. Buchheidt, et al.
Klinische Wochenschrift
|
February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum
D Fritze, B Massner, R Becher, et al.
Onkologie
|
April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"
H Flechtner, W Queisser, M E Heim, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]
A C Mayr, H J Senn, W M Gallmeier, et al.
American Journal of Surgery
|
November 1, 1976
Immunotherapy of cancer with "immune" RNA. A preliminary report
Y H Pilch, J B de Kernion, D G Skinner, et al.
Onkologie
|
November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer
G Hartung, R D Hofheinz, A Wein, et al.
Klinische Wochenschrift
|
June 15, 1982
A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer
D Fritze, R Becher, B Massner, et al.
International Journal of Systematic and Evolutionary Microbiology
|
July 2, 2009
Proposed minimal standards for describing new taxa of aerobic, endospore-forming bacteria
N A Logan, O Berge, A H Bishop, et al.
Anti-Cancer Drugs
|
August 13, 2005
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC
G von Minckwitz, I Chernozemsky, L Sirakova, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1981
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma
W Queisser, G Schnitzler, J Schaefer, et al.
Page
of 5